GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Scope Fluidics Spolka Akcyjna (WAR:SCP) » Definitions » Revenue

Scope Fluidics Spolka Akcyjna (WAR:SCP) Revenue : zł0.12 Mil (TTM As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Scope Fluidics Spolka Akcyjna Revenue?

Scope Fluidics Spolka Akcyjna's revenue for the three months ended in Sep. 2024 was zł0.02 Mil. Its revenue for the trailing twelve months (TTM) ended in Sep. 2024 was zł0.12 Mil. Scope Fluidics Spolka Akcyjna's Revenue per Share for the three months ended in Sep. 2024 was zł0.01. Its Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 was zł0.04.

During the past 12 months, the average Revenue per Share Growth Rate of Scope Fluidics Spolka Akcyjna was -86.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.


Scope Fluidics Spolka Akcyjna Revenue Historical Data

The historical data trend for Scope Fluidics Spolka Akcyjna's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Scope Fluidics Spolka Akcyjna Revenue Chart

Scope Fluidics Spolka Akcyjna Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Revenue
Get a 7-Day Free Trial - - - 0.40 0.52

Scope Fluidics Spolka Akcyjna Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.01 0.04 0.05 0.02

Competitive Comparison of Scope Fluidics Spolka Akcyjna's Revenue

For the Diagnostics & Research subindustry, Scope Fluidics Spolka Akcyjna's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Scope Fluidics Spolka Akcyjna's Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Scope Fluidics Spolka Akcyjna's Revenue distribution charts can be found below:

* The bar in red indicates where Scope Fluidics Spolka Akcyjna's Revenue falls into.


;
;

Scope Fluidics Spolka Akcyjna Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was zł0.12 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Scope Fluidics Spolka Akcyjna  (WAR:SCP) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Scope Fluidics Spolka Akcyjna Revenue Related Terms

Thank you for viewing the detailed overview of Scope Fluidics Spolka Akcyjna's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Scope Fluidics Spolka Akcyjna Business Description

Traded in Other Exchanges
Address
Duchnicka 3, Build 16, Entrance A, Warsaw, POL, 01-796
Scope Fluidics Spolka Akcyjna focuses on global challenges in health to develop diagnostic and med tech solutions. The company combines the expertise in microfluidic technology with the awareness of the challenges in medical diagnostics. It provides prototyping support for diagnostic services.

Scope Fluidics Spolka Akcyjna Headlines

No Headlines